Indian lab chain Dr. Lal Pathlabs is acquiring Delta RIA and Pathology Lab in Bhopal, Central India. Dr. Lal's IPO in December 2015 subscribed 33 times, raising Rs 190 crore (US$30m). Year-on-year sales in the first quarter of 2016 grew 15% to Rs 1977 crore (US$310m), with 26% EBITDA margin.